Ownership research and analyst forecasts provide insights into stock opportunities. Institutions own 50% of Immatics N.V. (NASDAQ:IMTX), indicating confidence in its future. Major shareholders like hedge funds influence stock performance, with dievini Hopp BioTech holding GmbH & Co.